ArticleBMJ case reports2025
Management of complex symptomatic renal artery aneurysm in a patient with Sjögren's syndrome and systemic lupus erythematosus.
Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal artery aneurysms (RAAs) are usually incidental findings during investigation of other pathologies; the majority remain asymptomatic. Larger RAAs can present with haematuria, hypertension, renal function decline, distal embolisation and even rupture. In this case report, we outline our novel approach in treating a complex type III RAA of a man in his 70s, who presented with right side abdominal and flank pain with persisting haematuria. The patient underwent a successful percutaneous endovascular procedure with placement of a C-Guard stent as a flow diverting device. Our satisfactory results, with preservation of all side branches, resolution of the patient's symptomatology, improvement of blood pressure control, persisted at 12 months follow-up, along with complete exclusion of the aneurysm from the circulation. The dual-layer design of the C-Guard stent, even though initially designed for treatment of carotid artery disease, effectively stabilised the aneurysm and safeguarded the side branches while minimising complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.